{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:09:19Z","timestamp":1792098559235,"version":"4.4.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T00:00:00Z","timestamp":1586822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T00:00:00Z","timestamp":1586822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1038\/s41574-020-0359-3","type":"journal-article","created":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T12:03:04Z","timestamp":1586865784000},"page":"303-304","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Vitamin D supplementation: a novel therapy for aldosteronism?"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7963-0931","authenticated-orcid":false,"given":"Gian Paolo","family":"Rossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia","family":"Lenzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,14]]},"reference":[{"key":"359_CR1","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14177","author":"NA Ismail","year":"2020","unstructured":"Ismail, N. A., Kamaruddin, N. A., Azhar Shah, S. & Sukor, N. The effect of vitamin D treatment on clinical and biochemical outcomes of primary aldosteronism. Clin. Endocrinol. https:\/\/doi.org\/10.1111\/cen.14177 (2020).","journal-title":"Clin. Endocrinol."},{"key":"359_CR2","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1016\/j.jacc.2019.09.057","volume":"74","author":"GP Rossi","year":"2019","unstructured":"Rossi, G. P. Primary aldosteronism: JACC State-of-the-Art Review. J. Am. Coll. Cardiol. 74, 2799\u20132811 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"359_CR3","doi-asserted-by":"publisher","first-page":"105434","DOI":"10.1016\/j.jsbmb.2019.105434","volume":"193","author":"X Gao","year":"2019","unstructured":"Gao, X. et al. The crosstalk between aldosterone and calcium metabolism in primary aldosteronism: A possible calcium metabolism-associated aberrant \u201cneoplastic\u201d steroidogenesis in adrenals. J. Steroid Biochem. Mol. Biol. 193, 105434 (2019).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"359_CR4","first-page":"E209","volume":"280","author":"G Mazzocchi","year":"2001","unstructured":"Mazzocchi, G., Aragona, F., Malendowicz, L. K. & Nussdorfer, G. G. PTH and PTH-related peptide enhance steroid secretion from human adrenocortical cells. Am. J. Physiol. Metab. 280, E209\u2013E213 (2001).","journal-title":"Am. J. Physiol. Metab."},{"key":"359_CR5","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1161\/01.CIR.0000155621.10213.06","volume":"111","author":"VS Chhokar","year":"2005","unstructured":"Chhokar, V. S. et al. Hyperparathyroidism and the calcium paradox of aldosteronism. Circulation 111, 871\u2013878 (2005).","journal-title":"Circulation"},{"key":"359_CR6","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1161\/HYPERTENSIONAHA.111.173948","volume":"58","author":"C Maniero","year":"2011","unstructured":"Maniero, C. et al. Primary hyperparathyroidism with concurrent primary aldosteronism. Hypertension 58, 341\u2013346 (2011).","journal-title":"Hypertension"},{"key":"359_CR7","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1097\/HJH.0b013e32834f0451","volume":"30","author":"C Maniero","year":"2012","unstructured":"Maniero, C. et al. Mild hyperparathyroidism: a novel surgically correctable feature of primary aldosteronism. J. Hypertens. 30, 390\u2013395 (2012).","journal-title":"J. Hypertens."},{"key":"359_CR8","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1161\/HYPERTENSIONAHA.112.195891","volume":"60","author":"GP Rossi","year":"2012","unstructured":"Rossi, G. P. et al. Hyperparathyroidism can be useful in the identification of primary aldosteronism due to aldosterone-producing adenoma. Hypertension 60, 431\u2013436 (2012).","journal-title":"Hypertension"},{"key":"359_CR9","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.1210\/jc.2019-00143","volume":"104","author":"L Lenzini","year":"2019","unstructured":"Lenzini, L. et al. PTH modulation by aldosterone and angiotensin II is blunted in hyperaldosteronism and rescued by adrenalectomy. J. Clin. Endocrinol. Metab 104, 3726\u20133734 (2019).","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"359_CR10","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1210\/jc.2011-0385","volume":"96","author":"MF Holick","year":"2011","unstructured":"Holick, M. F. et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 96, 1911\u20131930 (2011).","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41574-020-0359-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41574-020-0359-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41574-020-0359-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:48:47Z","timestamp":1684619327000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41574-020-0359-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,14]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["359"],"URL":"https:\/\/doi.org\/10.1038\/s41574-020-0359-3","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,14]]},"assertion":[{"value":"14 April 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}